Back in May, we provided an update on the status of AB2, the bill which would create Community Revitalization Investment Authorities, (see here). Things were relatively quiet over the summer but this ...
Swiss orphan biotech AB2 Bio Ltd. has completed enrollment in a pivotal phase III trial for its recombinant interleukin-18-binding protein drug tadekinig alfa for an inherited form of the ultra-rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results